|
Originally published In Press as doi:10.1074/jbc.M203518200 on July 15, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35019-35024, September 20, 2002
Stimulation of Enveloped Virus Infection by -Amyloid
Fibrils*
Woj M.
Wojtowicz ,
Michael
Farzan §,
John L.
Joyal¶,
Kara
Carter¶,
Gregory J.
Babcock §,
David I.
Israel¶,
Joseph
Sodroski § , and
Tajib
Mirzabekov¶**
From ¶ Praecis Pharmaceuticals, Inc., Waltham, Massachusetts
02451-4100 and the Department of Cancer Immunology and
AIDS, Dana-Farber Cancer Institute, § Department of
Pathology, Division of AIDS, Harvard Medical School, and
Department of Immunology and Infectious Disease, Harvard School
of Public Health, Boston, Massachusetts 02115
Alzheimer's disease is characterized by
deposition of -amyloid peptide (A ) into plaques in the brain,
leading to neuronal toxicity and dementia. Human immunodeficiency virus
type 1 (HIV-1) infection of the central nervous system can also cause a
dementia, and amyloid deposition in the central nervous system is
significantly higher in HIV-1-infected individuals compared with
uninfected controls. Here we report that A fibrils stimulated, by
5-20-fold, infection of target cells expressing CD4 and an appropriate
coreceptor by multiple HIV-1 isolates but did not permit infection of
cells lacking these receptors. A enhanced infection at the stage of virus attachment or entry into the cell. A fibrils also stimulated infection by amphotrophic Moloney leukemia virus, herpes simplex virus,
and viruses pseudotyped with the envelope glycoprotein of vesicular
stomatitis virus. Other synthetic fibril-forming peptides similarly
enhanced viral infection and may be useful in gene delivery
applications utilizing retroviral vectors. These data suggest
that A deposition may increase the vulnerability of the central
nervous system to enveloped viral infection and that amyloidogenic
peptides could be useful in enhancing gene transfer by enveloped viral vectors.
*
This work was supported by National Institutes of Health
Grants AI31783, AI41851, and AI46725, by Center for AIDS Research Grant
AI42848, and by gifts from the G. Harold and Leila Y. Mathers Charitable Foundation, the Friends 10, the late William F. McCarty-Cooper, and Douglas and Judith Krupp.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Praecis
Pharmaceuticals, Inc., 830 Winter St., Waltham, MA 02451-1420. Tel.:
781-795-4213; Fax: 781-795-4494; E-mail:
tajib.mirzabekov@praecis.com.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. E. Andras, G. Rha, W. Huang, S. Eum, P.-O. Couraud, I. A. Romero, B. Hennig, and M. Toborek
Simvastatin Protects against Amyloid {beta} and HIV-1 Tat-Induced Promoter Activities of Inflammatory Genes in Brain Endothelial Cells
Mol. Pharmacol.,
May 1, 2008;
73(5):
1424 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mori, T. Yokochi, N. Koide, T. Sugiyama, T. Yoshida, Y. Kimura, H. Naiki, R. Matsubara, T. Takeuchi, and Y. Nishiyama
PCR Search for the Herpes Simplex Virus Type 1 Genome in Brain Sections of Patients with Familial Alzheimer's Disease
J. Clin. Microbiol.,
February 1, 2004;
42(2):
936 - 937.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Strandberg, K. H. Pitkala, K. H. Linnavuori, and R. S. Tilvis
Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly Persons With Cardiovascular Diseases
Stroke,
September 1, 2003;
34(9):
2126 - 2131.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|